Prof Jennifer Keiser heads the Helminth Drug Development Unit at Swiss TPH, which maintains a large and unique set of helminth-rodent models. She is also a Professor of Neglected Tropical Diseases in the Faculty of Science at the University of Basel. Her team’s research objectives include in vitro and in vivo evaluations of the biological activities of chemical compounds, assay development, preclinical studies such as pharmacokinetics and metabolism and clinical trials in helminthiasis-endemic countries, particularly in Côte d’Ivoire, the Lao People’s Democratic Republic, Russia and Tanzania. Prof Keiser holds a five-year ERC Advanced Grant and is leading a five-year multi-partner EU grant to develop new drugs against neglected helminth infections.

Prof Jennifer Keiser leads the BRCCH project: FACEIT: Feasibility and Economic Evaluation of Improved Child Deworming. Read more here.

Dr Peter Steinmann is a trained epidemiologist and public health specialist and holds a habilitation (associate professorship) at the University of Basel. His research interests include the epidemiology and sustainable control of intestinal helminth and schistosome infections; the impact of intestinal parasite infections on child health, nutrition and well-being; the transmission of Mycobacterium leprae and post-exposure prophylaxis for contact and the elimination and eradication of neglected tropical diseases (NTDs). He has a track record of work related to NTDs and public health in over two dozen countries over the last 15 years, including four years in China. He is currently deputy head of unit. His technical expertise includes NTD research and control programme implementation in China, Central and South-East Asia, Africa and Brazil, public health, WASH, health systems, data quality and surveillance and epidemiological surveys.

Prof Peter Steinmann co- leads the BRCCH project: FACEIT: Feasibility and Economic Evaluation of Improved Child Deworming. Read more here.

Prof Fabrizio Tediosi leads the Health Systems and Policies group in the Department of Epidemiology and Public Health at the Swiss Tropical and Public Health Institute (Swiss TPH) and is a professor at the University of Basel. He holds a degree in economics and management from the University of Pavia, Italy, an MSc in health economics from the University of York, UK and a PhD in international public health from the University of Basel. He is an economist specializing in health policy analysis, the economic evaluation of priority setting, healthcare costing, the organization and financing of health systems, the economics of drugs, the economics of ageing and international development cooperation. His research interests also include universal health coverage, the economic and social implications of the elimination and eradication of neglected tropical diseases and global health governance.

Prof Fabrizio Tediosi co- leads the BRCCH project: FACEIT: Feasibility and Economic Evaluation of Improved Child Deworming. Read more here.

Prof Marc Pfister, MD, is a Professor of Pharmacometrics and Pharmacology in the Medical Faculty at the University of Basel, Chair of the Paediatric Pharmacology Department at University Children’s Hospital Basel (UKBB) and Head of SwissPedPha, the Swiss Platform for Pharmacology and Pharmacometrics Research in Paediatrics. He co-founded the American Conference on Pharmacometrics (ACoP) and the International Society of Pharmacometrics (ISoP). In the paediatric pharmacology research centre at UKBB, he leads a research group containing mathematicians, statisticians, engineers, pharmacologists and clinicians applying innovative pharmacometrics, control theory, machine learning and other AI-based approaches in order to develop clinical decision support systems with the goal of enhancing and personalizing treatments in neonates, infants, children and adolescents.

Prof Marc Pfister co-leads the BRCCH project: OptiThyDose: Intelligent Digital Decision Support Tool to Personalise Dosing for Children with Thyroid Diseases. Read more here.

Prof Gabor Szinnai is Head of Paediatric Endocrinology and Diabetology at University Children’s Hospital Basel (UKBB) and a research group leader in the Department of Clinical Research at University Hospital Basel. He trained in paediatric endocrinology in Basel and at L’Hôpital Necker – Enfants Malades in Paris, France. He is a board member of the National Committee for Rare Diseases (KOSEK) in Switzerland. His longstanding research interests are thyroid diseases in childhood with a special focus on genetic thyroid diseases and individualized pharmacotherapy for patients with thyroid diseases from birth to adulthood. He is a member of the Consensus Guideline Group for Congenital Hypothyroidism of the ENDO-European Reference Network (ERN) Initiative endorsed by the European Society for Paediatric Endocrinology (ESPE) and the European Society for Endocrinology (ESE). In 2012, he was awarded a Visiting Professorship Grant for Rare Endocrine Diseases by the ESPE.

Prof Gabor Szinnai co-leads the BRCCH project: OptiThyDose: Intelligent Digital Decision Support Tool to Personalise Dosing for Children with Thyroid Diseases. Read more here.

Dr. Britta Steffens studied mathematics at the University of Konstanz, Germany, specializing in statistics. She has more than 12 years of university-based experience in statistical modelling, pattern recognition and data analysis, as well as (undergraduate) teaching. In 2020, she joined the Paediatric Pharmacology Department at University Children’s Hospital Basel (UKBB) as an interdisciplinary scientific researcher. Her main research topics are the analysis and modelling of clinical data in the context of developing decision support tools by applying mathematical-statistical methods and approaches from pharmacometrics and machine learning.

Dr. Britta Steffens is a researcher in the BRCCH project: OptiThyDose: Intelligent Digital Decision Support Tool to Personalise Dosing for Children with Thyroid Diseases. Read more here.

Freya Bachmann is a PhD student in the Department of Mathematics and Statistics at the University of Konstanz, Germany. In collaboration with University Children’s Hospital Basel (UKBB), she applies techniques from optimal control theory and numerical optimization to pharmacometric models in order to compute optimal individualized dosing regimens. In 2019, she received the American Conference on Pharmacometrics Trainee Award for outstanding research and gave an oral presentation of her work entitled “Computing the Optimal Individual Dosing Regimen with Constraints on Model States to Include Side Effects” at the main conference in Florida.

Freya Bachmann is a researcher in the BRCCH project: OptiThyDose: Intelligent Digital Decision Support Tool to Personalise Dosing for Children with Thyroid Diseases. Read more here.